Generex Biotechnology provided an overview of the company's fiscal year ending July 31, 2019, with a string of acquisitions taking center stage.
The Latest
Biotechnology company DiscGenics treated the first Utahns in its nationwide clinical study of injectable disc cell therapy for degenerative disc disease.
NuVasive launched its Pulse system, which is designed to feature multiple technologies to assist surgeons in adopting more efficient and less disruptive surgical methods in spine procedures.
Here are 10 key notes on spine and orthopedic device companies:
St. Marys, Pa.-based Penn Highlands Healthcare plans to invest some $111 million to expand the system's presence in Clearfield, Pa., and DuBois, Pa., Gant News reports.
The Medicrea Group posted 16.1 million euros — about $18.1 million — in first half 2019 sales, down 5 percent year over year.
Revenues from Intuitive Surgical's da Vinci system could reach $1.5 billion by 2021, according to a Trefis market research report.
After residents filed a lawsuit to prevent Akron, Ohio-based Crystal Clinic's proposed 160,000-square-foot, $70 million orthopedic clinic, the orthopedic group is seeking approval for a backup site, the Akron Beacon Journal reports.
Christine Hammer, MD, will join Tacoma, Wash.-based CHI Franciscan Health when she completes her spine fellowship at Emory University School of Medicine this month.
Zachary Tempel, MD, is a neurosurgeon at Cincinnati-based Mayfield Brain & Spine. He specializes in complex spinal disorders, spine tumors, minimally invasive techniques and spine revision surgeries among others.